Related Experiment Videos
The G2 checkpoint-a node-based molecular switch
Mark C de Gooijer1, Arnout van den Top1, Irena Bockaj1
1Division of Pharmacology/Mouse Cancer Clinic The Netherlands Cancer Institute Amsterdam The Netherlands.
FEBS Open Bio
|April 12, 2017
Summary
The G2 checkpoint ensures genomic integrity by controlling cell cycle progression. A new model explains how Wee1 and CDC25C activities, regulated by PLK1 and CHK1, dictate the G2/M transition.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Eukaryotic cell cycle regulation is crucial for maintaining genomic stability.
- Cell cycle checkpoints prevent progression when DNA damage is detected.
- The G2 checkpoint specifically governs the transition from G2 phase to mitosis (M).
Purpose of the Study:
- To propose a node-based model for G2 checkpoint regulation.
- To elucidate the roles of key regulatory nodes in G2/M progression.
- To provide a framework for predicting the impact of targeting G2 checkpoint components.
Main Methods:
- Development of a node-based computational model.
- Analysis of regulatory interactions between CDK1-cyclin B1, Wee1, CDC25C, PLK1, and CHK1 nodes.
- Modeling of phosphorylation-dependent subcellular localization and degradation pathways.
Main Results:
- The model highlights the opposing roles of Wee1 and CDC25C nodes in regulating CDK1-cyclin B1 activity.
- Phosphorylation dictates Wee1 and CDC25C localization, influencing their nuclear or cytoplasmic activity and degradation.
- PLK1 and CHK1 nodes direct the 'nuclear and cytoplasmic decision states' of Wee1 and CDC25C.
Conclusions:
- The proposed model offers a simplified view of complex G2 checkpoint regulatory interactions.
- This framework helps understand the decision-making process for G2/M progression delay or continuation.
- The model can predict outcomes of therapeutic interventions targeting G2 checkpoint nodes.